ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - PFIZER INC/RECKITT BENCKISER/ALPHABET C Share Price

Certificat

Z06YOZ

CH1214882172

Market Closed - Swiss Exchange 08:50:00 22/05/2024 pm IST
102.8 CHF +0.28% Intraday chart for ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - PFIZER INC/RECKITT BENCKISER/ALPHABET C
Current month+10.58%
1 month+9.97%
Date Price Change

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 08:50 pm IST

More quotes

Static data

Product typeBonos de Acciones
Buy / SellCALL
Underlying PFIZER, INC.
Issuer ZKB
Z06YOZ
ISINCH1214882172
Date issued 06/02/2023
Strike 43.76 $
Maturity 06/08/2024 (71 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Ambos
Currency CHF

Technical Indicators

Highest since issue 102.9 CHF
Lowest since issue 89.16 CHF
Spread 7 CHF
Spread %0.68%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus
  1. Stock Market
  2. Certificates
  3. Z06YOZ Certificat